Prostate Treatment Outcomes Stage T1 & T2

Stage T1 & T2

 

NCCN guidelines recommend that life expectancy be compared to prostate cancer aggressiveness to appropriately select men whose best choice may be careful observation (active surveillance). RPCI follows the NCCN guidelines as evidenced by the percentage of men who choose observation for stages T1 & T2 prostate cancer.